Morgan Stanley Maintains Overweight on Accolade, Raises Price Target to $68

Morgan Stanley analyst Ricky Goldwasser maintains Accolade (NASDAQ:ACCD) with a Overweight and raises the price target from $60 to $68.

Morgan Stanley analyst Ricky Goldwasser maintains Accolade (NASDAQ:ACCD) with a Overweight and raises the price target from $60 to $68.

Total
0
Shares
Related Posts